Logo Beilstein Institut

Natural products in the predatory defence of the filamentous fungal pathogen Aspergillus fumigatus

  1. ‡,1,2 ORCID Logo ,
  2. ‡,1,2 ORCID Logo and
  3. 1 ORCID Logo
1Junior Research Group Evolution of Microbial Interactions, Leibniz-Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (HKI), Beutenbergstr. 11a, 07745 Jena, Germany
2Institute of Microbiology, Friedrich Schiller University Jena, Jena, Germany
  1. Corresponding author email
  2. ‡ Equal contributors
This article is part of the thematic issue "Chemical ecology".
Guest Editor: C. Beemelmanns
Beilstein J. Org. Chem. 2021, 17, 1814–1827. https://doi.org/10.3762/bjoc.17.124
Received 15 Jan 2021, Accepted 14 Jul 2021, Published 28 Jul 2021
Review
cc by logo
PDF
Album
Cite

Abstract

The kingdom of fungi comprises a large and highly diverse group of organisms that thrive in diverse natural environments. One factor to successfully confront challenges in their natural habitats is the capability to synthesize defensive secondary metabolites. The genetic potential for the production of secondary metabolites in fungi is high and numerous potential secondary metabolite gene clusters have been identified in sequenced fungal genomes. Their production may well be regulated by specific ecological conditions, such as the presence of microbial competitors, symbionts or predators. Here we exemplarily summarize our current knowledge on identified secondary metabolites of the pathogenic fungus Aspergillus fumigatus and their defensive function against (microbial) predators.

Keywords: amoeba predation; Aspergillus fumigatus; fungal ecology; non-ribosomal peptides; polyketides; secondary metabolism; virulence

Introduction

To thrive in their natural habitats all organisms from bacteria and fungi to plants and animals need access to sufficient nutritional sources and have to defend themselves against both, competitors and predators (Figure 1). Fungi are ubiquitous, living a mostly saprophytic, parasitic or symbiotic lifestyle in various habitats including soil, water, other organisms and even salt-flats and arctic glaciers [1,2]. As fungi are not able to physically leave their habitats they must rely on mechanical barriers, physiological adaptations and chemical defence mechanisms to optimize their living conditions and resist competitors, parasites and predators [3-5]. These bioactive compounds are often considered as secondary metabolites (SM) which are involved in communication, symbiotic interactions, pathogenicity or chemical defence, e.g., by toxin production [6]. With penicillin as the prime example fungal secondary metabolites have raised scientific and pharmaceutical interests for nearly one century. Today’s sequencing and bioinformatic analyses of fungal genomes revealed that the genetic potential far exceeds the number of known metabolites and the interest of scientists to gain access to them remains high [7-9].

[1860-5397-17-124-1]

Figure 1: Schematic overview of fungal interactions in the environment. Fungi can be found in essentially all terrestrial habitats comprising saprophytic, parasitic, symbiotic or predatory lifestyles [6]. Independent of their ecological niche, they have to protect themselves against abiotic stresses, competitors and predators while also communicating with their host or partners during parasitic/pathogenic or symbiotic interactions. This figure was created with biorender.com.

Genes associated with these bioactive compounds are often organized in biosynthetic gene clusters (BGCs) which are physically linked, commonly regulated and often belong to a few distinct classes of molecules like non-ribosomal peptides (NRP), polyketides (PK), terpenes or indole alkaloids [10,11]. The vast majority of fungal BGCs is found in the genomes of members of the Basidiomycota and Ascomycota including the genus Penicillium in which the first BGC was identified in 1990 [12-14]. Penicillium species belong to the Pezizomycotina, a subdivision within the Ascomycotina including several species that are closely associated with humans at many different levels. Aside from being a source of many medically relevant compounds including antibiotics like penicillin they offer food sources in the form of naturally grown truffles (e.g., Tuber melanosporum) or recently cultivated meat alternatives like Quorn® (Fusarium venenatum) [15-17]. Species of Aspergillus, such as Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger can affect the health of humans, plants and lifestock by acting as pathogens. It is firmly established that the ability to produce mycotoxins contributes to the virulence potential of these fungi, but as they all thrive in environmental reservoirs they must also provide an ecological advantage to their producer [18].

Indeed, many of these pathogenic fungi also produce compounds with antibacterial, antifungal and insecticidal properties to ward of both competitors and predators. The mycotoxins aflatoxin B1 (1) from Aspergillus flavus and patulin (2), produced by Aspergillus and Penicillium species, exhibit insecticidal activity against Drosophila melanogaster and might thus prevent feeding competition [19-21] (Figure 2). But not only mycotoxins protect from predation: A. flavus sclerotia are protected from sap beetles by asparasone and Neurospora crassa’s neurosporin A prevents springtail grazing [22,23]. Grazing by Folsomia candida springtails on Fusarium graminearum induces several metabolites, of which especially the bisnaphthopyrone pigment aurofusarin (3) was shown to have antifeedant effects not only on springtails but also on mealworm Tenebrio molitor and woodlouse Trichorhina tomentosa. Not only Fusarium species produce bisnaphthopyrones like aurofusarin but also Aspergillus and Penicilllium species produce these metabolites which show antifeedant effects on a wide variety of arthropods [24].

[1860-5397-17-124-2]

Figure 2: Fungal derived bioactive natural compounds with ecological and/or economic relevance.

Some fungal compounds can have deleterious effects on humans, livestock or crops, like the ergot alkaloids, e.g., ergotamine (4) present in the sclerotia of the ergot fungus Claviceps purpurea, which can contaminate grain products like flour. In the middle ages these contaminations caused vast epidemics of “St. Anthony’s fire”, a severe poisoning which could lead to death and mutilation in humans. However, midwives already knew the therapeutic potential of ergot alkaloids as early as 1582 and used it for abortion or to aid childbirth. The ecological significance of ergot alkaloids remains unclear, but they are assumed to be a feeding deterrent due to their toxicity and bad taste [25-28].

To trigger the synthesis of new SMs a number of approaches have been exploited so far, including co-cultivation with other species [9]. Amoebae offer promising possibilities to not only discover new SM but also to discover their ecological role as amoeba often cohabitate with fungi in their natural environments, especially the soil. Some, like Protostelium aurantium, were recently found to be exclusively fungivorous, feeding on both yeasts and filamentous fungi alike [29]. Additionally, amoeba closely resemble human phagocytic cells and the interactions of fungi and amoeba often parallels interactions of fungi and macrophages as was shown for Aspergillus fumigatus and its interactions with Acanthamoeba castellanii [30]. Thus, the adaptations that protect fungi against amoeba that were gained in the ‘environmental school of virulence’ might also protect fungi from the immune system [31]. Therefore, to study their interactions with human pathogenic fungi like A. fumigatus, one of the most common airborne fungal pathogens, might lead to new insight in virulence mechanisms and the role of SMs therein [32]. The aim of this review is to depict the fungal secondary metabolite potential and its role in an ecological context using A. fumigatus as an example because of its high medical importance and its diverse profile of secondary metabolites which seems to fulfil dual roles: targeting innate immune cells during virulence and protect from environmental predators in natural habitats.

Review

Natural products of Aspergillus fumigatus

The genus Aspergillus comprises a large number of species that are not only of scientific but also of pharmaceutical and commercial interest. While the non-pathogenic A. niger is used as industrial workhorse, for example in the production of citric acid, other representatives contaminate food stocks with mycotoxins (A. flavus) or can cause severe infections (A. fumigatus, A. terreus). Despite their different role for humans, they commonly share a high potential for the production of secondary metabolites, measured by the predicted number of secondary metabolite gene clusters identified by numerous genome sequencing projects. Due to its clinical importance as an opportunistic pathogen A. fumigatus is of great interest among them [33,34].

As a saprophytic decomposer of organic material in the soil, A. fumigatus encounters not only numerous competitors but also fungivorous predators like amoebae (e.g., P. aurantium), nematodes (e.g., Aphelenchus avenae) or arthropods like insects, mites and springtails (e.g., F. candida) [35-39]. However, the fungus may also act as a pathogen causing often lethal infections in immune-compromised patients, and thus its secondary metabolism was extensively studied in recent years [38,40,41]. Analysis of the A. fumigatus genome sequence and metabolomics revealed its potential to synthesize more than 200 compounds and the presence of over 30 secondary metabolite associated gene clusters [7,42-44]. The products of many of those gene clusters are already known and span the whole range of secondary metabolite classes. Table 1 provides an overview of the major secondary metabolites from A. fumigatus and lists their ecological roles as well as their impact on virulence.

Table 1: Overview of Aspergillus fumigatus secondary metabolites and their roles during virulence and in their ecological context.

Metabolite Class Virulence factor Role in virulence Ecological role/ toxicity Reference
DHN-melanin polyketide, phenolic polymer, pigment yes - prevents recognition by the immune system
- prevents phagosomal acidification 		- protection against UV-stress
- prevents recognition by predators (e.g., amoeba)
- prevents phagolysosome maturation 		[45-50]
endocrocin polyketide, pigment – - inhibits chemotaxis of neutrophils - protection against UV-stress [47,51-53]
ferricrocin siderophore yes - iron homeostasis - iron homeostasis [54,55]
fumagillin mero-terpenoid – - inhibitor of phagocyte activity
- damages epithelial cells
- inhibitor of methionine aminopeptidase 		- cilioinhibitory
- antimicrobial
- antiprotozoal 		[56-62]
fumigaclavine ergot alkaloid – - reduces production of TNF-α – toxic to mammalian cells - antibacterial
- insecticidal
- antifeedant 		[63-67]
fumipyrrole non-ribosomal peptide – – - enhances growth and sporulation [68]
fumiquinozalines tryptophan derived peptidyl alkaloid – not determined - antibacterial
- antifungal 		[69-72]
fumisoquin isoquinolone alkaloid – not determined - inhibits bacterial replication [73,74]
fumitremorgin indole diketo-piperazine alkaloid – - inhibitor of breast cancer resistance protein - antifungal
- antifeedant
- insecticidal 		[72,75]
fusarinine C/ triacetylfusarinine C siderophore yes - iron acquisition - iron acquisition [54,55,76]
fungisporin non-ribosomal peptide – not determined - antibacterial [41,77]
gliotoxin epipolythiopiperazine yes - inhibition of immune response - cilioinhibitory
- antimicrobial
- protects against amoeba predation 		[78-82]
helvolic acid/ protostadienol fusidane-type steroid – - cilioinhibitory - antibacterial
- antiprotozoal
- antifungal 		[72,83-88]
hexadehydro- astechrome non-ribosomal peptide, tryptophan-derived iron(III) complex yes - iron homeostasis - iron homeostasis [89,90]
neosartoricin/ fumicycline prenylated polyketide, meroterpenoid – - inhibition of immune response not determined [41,91,92]
nidulanin A tetracyclo-peptide/
isoprene 		– not determined not determined [93]
pseurotin heterocyclic γ-lactam – - inhibition of IgE production - antibacterial [94-97]
pyripyropene A sesqui-terpenoid – - acetyltransferase inhibitor - nematicide
- insecticidal 		[98-100]
sphingofungin A–D sphingosine-like compound not determined - inhibition of serine palmitoyl transferase - antifungal [101-104]
trypacidin polyketide, anthraquinone, pigment – - toxic to lung cells - antiprotozoal
- antiphagocytic 		[53,105-107]
verruculogen indole diketo-piperazine alkaloid not determined - alters electrophysical properties of human nasal epithelial cells - antifungal [72,108-110]
xanthocillin tyrosine-derived isocyanide – - copper homeostasis - copper homeostasis [111]

Gliotoxin

Gliotoxin (GT, 5) is the non-ribosomal peptide (NRP) derived epipolythiodioxopiperazine (ETP’s) class toxin of several fungal genera including Aspergillus, Penicillium, Trichoderma, and Leptosphaera (Figure 3) [112]. Among the ascomycetes, A. fumigatus may well be the major GT producer and the identification of its heterocyclic structure by Bell and colleagues in 1958 builds the foundation to understand its role in invasive aspergillosis [113]. In A. fumigatus 13 genes form a 28 kb biosynthetic cluster of gliotoxin, of which gliZ (a zinc-finger transcription factor) and gliP (an NRPS) together with global regulator LaeA regulate its expression at the genomic level [112,114-116] (Figure 3). Whereas GliT (a gliotoxin oxidoreductase) catalyses the oxidation of reactive dithiol gliotoxin (6) to gliotoxin and a distantly localized S-adenosylmethionine-dependent gliotoxin bisthiomethyltransferase (GtmA) is responsible for the formation of bis(methyl)gliotoxin (7) to maintain the GT concentration at sub-lethal levels via redox cycling and S-methylation of active disulfides in GT, respectively [117,118]. Furthermore, in terms of exogenous factors, not only GT itself but several other biotic and abiotic factors, including neutrophilic granulocytes, media composition, pH, temperature and aeration, are known to regulate gliotoxin biosynthesis [115,119,120].

[1860-5397-17-124-3]

Figure 3: Gliotoxin biosynthetic gene cluster and it major biosynthetic transformations: Gliotoxin (5) is the oxidized form of dithiol-gliotoxin (6) catalysed by the gliotoxin oxidoreductase GliT. Dithiol-gliotoxin can be methylated to bis(methyl)gliotoxin (7) via the S-adenosyl-methionine (SAM) dependent bisthiomethyltransferase GtmA which is not part of the gli-cluster.

The biological activity of ETP’s like gliotoxin is mediated by the active disulfide bridge that targets vulnerable thiols or catalyses oxidative burst formation via redox cycling [78]. In previous studies, these cytotoxic activities of gliotoxin were shown to be immunosuppressive in humans [79-81]. Sugui and colleagues (2007) also demonstrated that a gliotoxin lacking strain of A. fumigatus is avirulent in mice treated with cortisone acetate [121]. Nevertheless, the fact that gliotoxin is not only produced by pathogenic A. fumigatus suggests a role of gliotoxin in natural microenvironments. In vitro studies have also revealed the amoebicidal activities of gliotoxin on its natural co-inhabitant Dictyostelium discoideum [82]. However, these pathogenic activities sometimes prove to be beneficial for other co-habitants, comparable to how Trichoderma virens protects cotton seedlings from its pathogen Pythium ultimum [122].

Trypacidin

The spore-born toxin trypacidin (8) is a polyketide that belongs to an anthraquinone-derived class of secondary metabolites (Figure 4) [107]. In A. fumigatus, the trypacidin biosynthetic cluster (tpc) is comprised of 13 genes that spans over a 25 kb sub-telomeric region on chromosome 4 [53,105]. It is one of the conidial secondary metabolites that are regulated by global transcriptional regulators LaeA and BrlA in A. fumigatus [51,123-126]. Nevertheless, trypacidin production is also regulated by cluster specific transcriptional regulators TpcD/E [53]. Though the precise mechanism of action of trypacidin remains to be elucidated, it was shown to exhibit antiprotozoal, antiphagocytic and cytotoxic activities in vitro. Gauthier and colleagues (2012) have shown that in lung cells trypacidin mediates in necrosis-mediated death [107]. In another study, absence of trypacidin was shown to be linked with increased phagocytic rates in murine alveolar macrophages and phagocytic amoeba D. discoideum. The authors further showed that trypacidin reduced the viability of amoebae which signifies its role in conidial protection in the environment [105].

[1860-5397-17-124-4]

Figure 4: Amoebicidal secondary metabolites trypacidin and fumagillin of Aspergillus fumigatus.

Fumagillin

Fumagillin (9) belongs to the meroterpenoid class of secondary metabolites. It was discovered in 1949 from A. fumigatus [127]. Strikingly, unlike other secondary metabolite synthesizing clusters, the fumagillin biosynthetic cluster is intertwined with the pseurotin gene cluster and designated as the fma cluster [95,128]. Wiemann and colleagues (2013) have shown the existence of a similarly intertwined pattern in both close and distant relatives of A. fumigatus, and therefore suggested a role of these metabolites in survival. In A. fumigatus, the fma cluster is located on the sub-telomeric region on chromosome 8 and is comprised of 15 genes. At the cellular level fumagillin is regulated by both cluster specific regulator FumR (FapR) and global regulator LaeA [95].

Fumagillin consists of a cyclohexane ring and decatetraenedioic acid connected via an ester bond. There is also a methoxy group, an epoxide and a terpene derived aliphatic chain that contains another epoxide, linked to cyclohexane. These unstable di-epoxides are responsible for the biological activity of fumagillin, which targets the active site of the methionine aminopeptidase type-2 (MetAP-2) enzyme [129]. MetAP-2 is involved in cell proliferation, translation and post-translational modifications of nascent polypeptides and is therefore essential for cell viability [130,131]. Additionally, fumagillin is also known to be overproduced upon caspofungin treatment and damage to the cell walls while fumagillin aids in immune evasion by reducing ROS levels, degranulation and actin filamentation in neutrophils [60,132]. In nature, several fungal species are known to produce caspofungin which could trigger fumagillin production in natural environments [132,133]. A. fumigatus possesses an additional MetAP-2 gene in the fma cluster that protects itself against its own toxin [134]. Fumagillin has therapeutic potential for the treatment of intestinal microsporidiosis and nosemiasis in honey bees [58,135]. Overall, antibiotic, immunosuppressive, antitumor and antiangiogenic properties have been attributed to fumagillin [129,136-140]. Specific antibiotic activities were demonstrated against the pathogen Entamoeba histolytica and later against eukaryotic parasites such as Trypanosoma and Plasmodium the causative agent of malaria [141,142]. In comparison to gliotoxin, we found only minor cytotoxic activities of fumagillin against the model amoebae D. discoideum [82]. It could still be conceivable that other amoeba could reveal higher sensitivity, but tests against the fungivorous amoeba P. aurantium were not yet conducted.

DHN-melanin

Melanins are a heterogenous group of hydrophobic phenolic polymers that are found in a range of organisms including bacteria, plants, fungi and even animals. The melanin pigments are of mostly dark colours like black or brown and are associated with virulence in plant- and animal-pathogenic fungi [143-145]. Three types of melanins are known to be produced by fungi of which A. fumigatus is able to produce two – pyomelanin and dihydroxynaphthalene melanin (DHN-melanin). While the water-soluble pyomelanin is synthesized via the tyrosine degradation pathway, the DHN-melanin synthesis relies on its own SM-gene-cluster [146-148]. The DHN-melanin of A. fumigatus is a heteropolymer formed through the polymerization of 1,8-dihydroxynaphtalene (1,8-DHN) monomers (10) and is responsible for the unique greyish-green colour of A. fumigatus conidia (Figure 5).

[1860-5397-17-124-5]

Figure 5: Intermediates of the DHN-melanin biosynthesis in Aspergillus fumigatus.

The genetics and biochemistry of its biosynthesis are well established: the 19 kb gene cluster contains 6 genes and lies downstream of the conidiation pathway. The polyketide synthase PksP combines the starter units acetyl-CoA and malonyl-CoA into the heptaketide naphthopyrone YWA1 (11). The hydrolytic activity of Ayg1 shortens the heptaketide to the pentaketide 1,3,6,8-tetrahydroxynaphthalene (1,3,6,8-THN) (12) and is further reduced by reductase Arp2 to scytalone (13), which in turn is dehydrated by Arp1 to 1,3,8-trihydroxynaphthalene (1,3,8-THN) (14). Again, Arp2 reduces 1,3,8-THN to vermelone (15) before it is dehydrated to 1,8-dihydroxynaphthalene (1,8-DHN) (10) by Abr1, a multi-copper reductase. In a last step polymerization of 1,8-DHN monomers is facilitated by the laccase Abr2 [45,149-152]. Knock out mutants of either ayg1, arp2, or abr2 lead to different coloured conidia while loss of pksP aborts DHN-melanin synthesis completely which leads to white spores [45]. DHN-melanin is a heterogeneous polymer, as such it does not have a unique structure. Its insolubility aggravates any structural analyses of the deciphering of repetitive motives. However, there were studies doing either computational predictions or artificial oxidative polymerization studies of 1,8-DHN monomers [144,153].

Next to offering the conidia protection from UV radiation, DHN-melanin was shown to be a key factor to survival during both predation and virulence. When preyed upon by fungivorous amoeba like P. aurantium melanised conidia where not only internalized less than ΔpksP conidia but were also able to prevent maturation of phagolysosomes [50,147]. During infection DHN-melanin masks the pathogen-associated molecular patterns on the spore-surface and is thus less likely to be recognized by the immune system. The ΔpksP strain lacks this protection and is more easily recognized by the immune system, thus triggering a stronger immune response, including a higher pro-inflammatory response and increased recognition and ingestion by phagocytes rendering the ΔpksP strain less virulent. Additionally, melanised conidia are more likely to survive internalization by lung epithelial cells [147,154,155]. Although DHN-melanin is generally associated with immune evasion it was recently found to be recognized in higher animals via the C-type lectin receptor (MelLec) which interacts with the naphthalene-diol domain of DHN-melanin. Additionally, the surfactant protein D (SP-D), a soluble C-type lectin receptor (CLR), is also able to recognise DHN-melanin and opsonize it to increase the immune response. However, MelLec receptors are only present on some endothelial and myeloid cells [156,157].

Fumigaclavines

Fumigaclavine C (19) is a tryptophan-derived indole alkaloid which was so far only shown to be produced by A. fumigatus while other fumigaclavines can for example also be found in Penicillium ssp. (fumigaclavine A (18) and B (17)) [66,158]. In all fungi, alkaloid biosynthetic pathways share a common basis, starting with the prenylation of ʟ-tryptophan to dimethylallyltryptophan (DMAT). During several steps DMAT is converted to chanoclavine-I aldehyde, the last mutual intermediate. Branching into different pathways after this intermediate is mainly due to differences in the function of EasA, the enzyme catalysing the next biosynthetic step. In A. fumigatus EasA acts as a reductase and after additional steps chanoclavine-I aldehyde is converted into festuclavine (16) (Figure 6). Festuclavine is then oxidized to fumigaclavine B (17) which in turn is acetylated to fumigaclavine A (18). Finally a reverse prenylation of fumigaclavine A leads to fumigaclavine C (19), the final product of fumigaclavine biosynthesis [159]. Biosynthesis of the intermediate festuclavine as well as fumigaclavines A–C is dependent on LaeA regulation [124].

[1860-5397-17-124-6]

Figure 6: Intermediates and products of the fumigaclavine C biosynthesis.

Its numerous bioactive effects hold the potential for a pharmaceutical use since it was shown to be an effective inhibitor of tumor necrosis factor-alpha (TNF-α) production by preventing the activation of TLR4 by lipopolysaccharide (LPS) and was thus proposed for potential use against atherosclerosis [67]. Furthermore fumigaclavine C has also proven effective against MCF-7 breast cancer cells by arresting the cell cycle and promoting apoptosis while showing no cytotoxicity against RAW 264.7 cells, thus demonstrating their selectivity [65,67]. Further, fumigaclavine was shown to exhibit antibacterial properties and to contribute to virulence in the model insect Galleria mellonella [66].

Fumitremorgins

The class of fumitremorgins comprises several diketopiperazine alkaloids which are tremorgenic mycotoxins. However, there are several fumitremorgin-like indole alkaloids including tryprostatins, spiro- and cyclotryprostatins and verruculogen besides fumitremorgins themselves. They occur most often in Aspergillus and Penicillium species [160]. Fumitremorgin A (20), B (21) and C (22) can all be found in A. fumigatus (Figure 7). They are based on the precursers ʟ-tryptophan and ʟ-proline and are further derived from breviamide F, proposedly via tryprostatin B which is hydroxylated and methylated to tryprostatin A. Oxidative closure of the ringstructure then results in fumitremorgin C. Further modification of the structure leads to fumitremorgin B and verruculogen, which shares the same pathway [97,160-162]. Which enzyme is responsible for the conversion of verruculogen to fumitremorgin A remains to be elucidated. Like several other clusters, the biosynthesis of fumitremorgins is dependent on LaeA [124].

[1860-5397-17-124-7]

Figure 7: Bioactive secondary metabolites of Aspergillus fumigatus.

Fumitremorgin B was shown to have antifungal properties against phytopathogenic fungi, antifeedant properties against army-worm larvae and toxic on brine shrimp [72]. It was further shown to be cytotoxic and inhibiting cell cycle progression at G2/M phase [163]. Fumitremorgin C was shown to effect mammalian cells and inhibit the breast cancer resistance protein which imparts multidrug resistance and thus resistance to chemotherapeutics in breast cancer treatment [75,164].

Helvolic acid

Helvolic acid (HA) (23) is a fusidane-type antibiotic that belongs to the triterpenoid class of secondary metabolites. Originally, it was discovered from A. fumigatus but later several other members of the sub phylum Pezizomycotina were also found to be HA producers [165-168]. In A. fumigatus, the biosynthetic cluster of HA is comprised of 9 genes that spans over a 16.3 kb region on chromosome 4 (Figure 8). The cluster contains an oxidosqualine cyclase (helA), three Cytochrome P450 (helB1, helB2, helB3), a short-chain dehydrogenase/reductase (helC) and two acetyltransferases (helD1, helD2) and a 3-ketosteroid-Δ1-dehydrogenase [83,169]. Helvolic acid is a tetracyclic compound containing two keto groups, two acetates and one carboxyl group which do not equally contribute to function [169]. Lv and colleagues have shown that the presence of both the C-20 carboxyl group and the 3-keto group are crucial for its antibacterial activity whereas, acetylation of the C-6 hydroxy group reduces the activity of HA [169]. Previous studies have also shown the antitrypanosomal, antifungal and cilioinhibitory properties of HA [72,83,86-88]. For these properties and little cross-resistance helvolic acid is of great pharmaceutical importance. On the other hand, these antibiotic activities of HA could alter the soil microflora in natural habitats, an ecological role of HA that requires further investigation.

[1860-5397-17-124-8]

Figure 8: Helvolic acid gene cluster of A. fumigatus.

Pyripyropene A

Pyripyropene A (PPPA) (24) belongs to the meroterpenoid class of secondary metabolites. It was originally isolated from A. fumigatus, but later several other pyripyropene A producing members of Aspergillus and Penicillium ssp. were identified [98,99,170,171]. In A. fumigatus 9 genes form a pyripyropene A (pyr) biosynthetic cluster that spans a 23 kb region on chromosome 6 [172]. Chemically, pyripyropene (PP) analogs are meroterpenoids containing a fused pyridyl α-pyrone moiety and eight contiguous stereocenters [170]. Metabolically, PPPA non-covalently binds within the fifth transmembrane domain of acyl-coenzyme A (CoA):cholesterol acyltransferase ACAT2 and renders it inactive [173]. In vivo, PPPA-mediated ACAT2 inhibition was shown to protect the mice from atherosclerosis, ACAT2 enzyme mediates in lipid metabolism and is localized in the liver and intestines [174]. Furthermore, PPPA was also shown to exhibit insecticidal properties against aphids [100].

Conclusion

Increasing access to sequenced microbial genomes offers a glimpse at the untapped potential we have yet to gain access to. Fungi in particular harbor great potential to produce novel secondary metabolites with ecological and pathogenic importance. As a medically relevant fungal pathogen A. fumigatus is the subject of much research and since sequencing of its genome in 2005 its potential for the production of secondary metabolites was scrutinized frequently [7,43,175]. In recent years many of its BGCs could be matched with either long known or newly discovered bioactive compounds and while the bioactive potential and the ecological role of many well studied metabolites like DHN-melanin or gliotoxin is well known, newer metabolites often cannot be associated with a biological function. Due to its clinical significance, the highest interest in secondary metabolites of A. fumigatus was driven by its pathobiology, e.g., a role in cytotoxicity, immunosuppression or antifungal drug resistance. In natural habitats these molecules may fulfill analogous functions, such as the defense against phagocytic predators by gliotoxin [78-82]. Indeed, the need for survival is the driving force of evolution and fungi like A. fumigatus were able to cultivate an impressive arsenal of protective mechanism from DHN-melanin which offers mostly passive protection to more active compounds like fumigaclavines or helvolic acid with their antibacterial and antifungal activities, respectively [50,63,72,147]. Since SM activities are most often closely related to ecological conditions mimicking of more natural cultivation conditions might lead to the discovery of new compounds and their ecological role.

In the past few years, protists like D. discoideum and Acanthamoeba castellani have been widely used for the identification of virulence attributes of pathogenic fungi, including Aspergillus spp., for their similarity with human phagocytic cells [32]. Nevertheless, the precise identity of amoeboid, nematode and arthropod predators that target filamentous fungi in their environmental niches remained elusive and has been limited by their biological complexity. It was thus surprising to find that the environmentally abundant, fungivorous amoeba P. aurantium does not only graze on yeast but can specifically target filamentous fungi such as A. fumigatus. The mechanism of action was coined ruphocytosis and involved a locally distinct disruption of the cell wall of the fungal hyphae to feed on the fungal cytoplasm [29]. It is well conceivable that this amoeba will target a range of different filamentous fungi, and that this biotic cell wall stress can be exploited as an ecological trigger for the production and identification of new bioactive compounds in the future.

Funding

Work in the authors’ lab was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Startegy - EXC 2051 - Project-ID 390713860 and the research grants DFG HI1574/2-1 und HI1574/4-1. The graphical abstract and Figure 1 were created with BioRender.com.

References

  1. Blackwell, M. Am. J. Bot. 2011, 98, 426–438. doi:10.3732/ajb.1000298
    Return to citation in text: [1]
  2. Cantrell, S. A.; Dianese, J. C.; Fell, J.; Gunde-Cimerman, N.; Zalar, P. Mycologia 2011, 103, 1161–1174. doi:10.3852/11-108
    Return to citation in text: [1]
  3. Sutherland, I. W. Trends Microbiol. 2001, 9, 222–227. doi:10.1016/s0966-842x(01)02012-1
    Return to citation in text: [1]
  4. Costa-Orlandi, C. B.; Sardi, J. C. O.; Pitangui, N. S.; de Oliveira, H. C.; Scorzoni, L.; Galeane, M. C.; Medina-Alarcón, K. P.; Melo, W.; Marcelino, M. Y.; Braz, J. D.; Fusco-Almeida, A. M.; Mendes-Giannini, M. J. S. J. Fungi 2017, 3. doi:10.3390/jof3020022
    Return to citation in text: [1]
  5. Kowalski, C. H.; Morelli, K. A.; Schultz, D.; Nadell, C. D.; Cramer, R. A. Proc. Natl. Acad. Sci. U. S. A. 2020, 117, 22473–22483. doi:10.1073/pnas.2003700117
    Return to citation in text: [1]
  6. Spiteller, P. Nat. Prod. Rep. 2015, 32, 971–993. doi:10.1039/c4np00166d
    Return to citation in text: [1] [2]
  7. Nierman, W. C.; Pain, A.; Anderson, M. J.; Wortman, J. R.; Kim, H. S.; Arroyo, J.; Berriman, M.; Abe, K.; Archer, D. B.; Bermejo, C.; Bennett, J.; Bowyer, P.; Chen, D.; Collins, M.; Coulsen, R.; Davies, R.; Dyer, P. S.; Farman, M.; Fedorova, N.; Fedorova, N.; Feldblyum, T. V.; Fischer, R.; Fosker, N.; Fraser, A.; García, J. L.; García, M. J.; Goble, A.; Goldman, G. H.; Gomi, K.; Griffith-Jones, S.; Gwilliam, R.; Haas, B.; Haas, H.; Harris, D.; Horiuchi, H.; Huang, J.; Humphray, S.; Jiménez, J.; Keller, N.; Khouri, H.; Kitamoto, K.; Kobayashi, T.; Konzack, S.; Kulkarni, R.; Kumagai, T.; Lafton, A.; Latgé, J.-P.; Li, W.; Lord, A.; Lu, C.; Majoros, W. H.; May, G. S.; Miller, B. L.; Mohamoud, Y.; Molina, M.; Monod, M.; Mouyna, I.; Mulligan, S.; Murphy, L.; O'Neil, S.; Paulsen, I.; Peñalva, M. A.; Pertea, M.; Price, C.; Pritchard, B. L.; Quail, M. A.; Rabbinowitsch, E.; Rawlins, N.; Rajandream, M.-A.; Reichard, U.; Renauld, H.; Robson, G. D.; de Córdoba, S. R.; Rodríguez-Peña, J. M.; Ronning, C. M.; Rutter, S.; Salzberg, S. L.; Sanchez, M.; Sánchez-Ferrero, J. C.; Saunders, D.; Seeger, K.; Squares, R.; Squares, S.; Takeuchi, M.; Tekaia, F.; Turner, G.; de Aldana, C. R. V.; Weidman, J.; White, O.; Woodward, J.; Yu, J.-H.; Fraser, C.; Galagan, J. E.; Asai, K.; Machida, M.; Hall, N.; Barrell, B.; Denning, D. W. Nature 2005, 438, 1151–1156. doi:10.1038/nature04332
    Return to citation in text: [1] [2] [3]
  8. Khaldi, N.; Seifuddin, F. T.; Turner, G.; Haft, D.; Nierman, W. C.; Wolfe, K. H.; Fedorova, N. D. Fungal Genet. Biol. 2010, 47, 736–741. doi:10.1016/j.fgb.2010.06.003
    Return to citation in text: [1]
  9. Brakhage, A. A.; Schroeckh, V. Fungal Genet. Biol. 2011, 48, 15–22. doi:10.1016/j.fgb.2010.04.004
    Return to citation in text: [1] [2]
  10. Keller, N. P.; Turner, G.; Bennett, J. W. Nat. Rev. Microbiol. 2005, 3, 937–947. doi:10.1038/nrmicro1286
    Return to citation in text: [1]
  11. Gacek, A.; Strauss, J. Appl. Microbiol. Biotechnol. 2012, 95, 1389–1404. doi:10.1007/s00253-012-4208-8
    Return to citation in text: [1]
  12. Krause, D. J.; Kominek, J.; Opulente, D. A.; Shen, X.-X.; Zhou, X.; Langdon, Q. K.; DeVirgilio, J.; Hulfachor, A. B.; Kurtzman, C. P.; Rokas, A.; Hittinger, C. T. Proc. Natl. Acad. Sci. U. S. A. 2018, 115, 11030–11035. doi:10.1073/pnas.1806268115
    Return to citation in text: [1]
  13. Smith, D. J.; Burnham, M. K. R.; Edwards, J.; Earl, A. J.; Turner, G. Bio/Technology 1990, 8, 39–41. doi:10.1038/nbt0190-39
    Return to citation in text: [1]
  14. Keller, N. P. Nat. Rev. Microbiol. 2019, 17, 167–180. doi:10.1038/s41579-018-0121-1
    Return to citation in text: [1]
  15. O'Donnell, K.; Cigelnik, E.; Casper, H. H. Fungal Genet. Biol. 1998, 23, 57–67. doi:10.1006/fgbi.1997.1018
    Return to citation in text: [1]
  16. Martin, F.; Kohler, A.; Murat, C.; Balestrini, R.; Coutinho, P. M.; Jaillon, O.; Montanini, B.; Morin, E.; Noel, B.; Percudani, R.; Porcel, B.; Rubini, A.; Amicucci, A.; Amselem, J.; Anthouard, V.; Arcioni, S.; Artiguenave, F.; Aury, J.-M.; Ballario, P.; Bolchi, A.; Brenna, A.; Brun, A.; Buée, M.; Cantarel, B.; Chevalier, G.; Couloux, A.; Da Silva, C.; Denoeud, F.; Duplessis, S.; Ghignone, S.; Hilselberger, B.; Iotti, M.; Marçais, B.; Mello, A.; Miranda, M.; Pacioni, G.; Quesneville, H.; Riccioni, C.; Ruotolo, R.; Splivallo, R.; Stocchi, V.; Tisserant, E.; Viscomi, A. R.; Zambonelli, A.; Zampieri, E.; Henrissat, B.; Lebrun, M.-H.; Paolocci, F.; Bonfante, P.; Ottonello, S.; Wincker, P. Nature 2010, 464, 1033–1038. doi:10.1038/nature08867
    Return to citation in text: [1]
  17. Karwehl, S.; Stadler, M. Exploitation of Fungal Biodiversity for Discovery of Novel Antibiotics. In How to Overcome the Antibiotic Crisis : Facts, Challenges, Technologies and Future Perspectives; Stadler, M.; Dersch, P., Eds.; Springer International Publishing: Cham, Switzerland, 2016; pp 303–338. doi:10.1007/82_2016_496
    Return to citation in text: [1]
  18. Spiteller, P. Chem. – Eur. J. 2008, 14, 9100–9110. doi:10.1002/chem.200800292
    Return to citation in text: [1]
  19. Zeng, R. S. L.; Niu, G.; Wen, Z.; Schuler, M. A.; Berenbaum, M. R. J. Chem. Ecol. 2006, 32, 1459–1471. doi:10.1007/s10886-006-9062-7
    Return to citation in text: [1]
  20. González-Osnaya, L.; Soriano, J. M.; Moltó, J. C.; Mañes, J. Food Addit. Contam. 2007, 24, 1268–1274. doi:10.1080/02652030701361556
    Return to citation in text: [1]
  21. Reiss, J. Chem.-Biol. Interact. 1975, 10, 339–342. doi:10.1016/0009-2797(75)90055-1
    Return to citation in text: [1]
  22. Cary, J. W.; Harris-Coward, P. Y.; Ehrlich, K. C.; Di Mavungu, J. D.; Malysheva, S. V.; De Saeger, S.; Dowd, P. F.; Shantappa, S.; Martens, S. L.; Calvo, A. M. Fungal Genet. Biol. 2014, 64, 25–35. doi:10.1016/j.fgb.2014.01.001
    Return to citation in text: [1]
  23. Zhao, Y.; Ding, J.; Yuan, W.; Huang, J.; Huang, W.; Wang, Y.; Zheng, W. Environ. Microbiol. 2017, 19, 3920–3929. doi:10.1111/1462-2920.13791
    Return to citation in text: [1]
  24. Xu, Y.; Vinas, M.; Alsarrag, A.; Su, L.; Pfohl, K.; Rohlfs, M.; Schäfer, W.; Chen, W.; Karlovsky, P. Nat. Commun. 2019, 10, 3579. doi:10.1038/s41467-019-11377-5
    Return to citation in text: [1]
  25. Eadie, M. J. Lancet Neurol. 2003, 2, 429–434. doi:10.1016/s1474-4422(03)00439-3
    Return to citation in text: [1]
  26. Tudzynski, P.; Correia, T.; Keller, U. Appl. Microbiol. Biotechnol. 2001, 57, 593–605. doi:10.1007/s002530100801
    Return to citation in text: [1]
  27. Tudzynski, P.; Scheffer, J. Mol. Plant Pathol. 2004, 5, 377–388. doi:10.1111/j.1364-3703.2004.00237.x
    Return to citation in text: [1]
  28. Schardl, C. L.; Panaccione, D. G.; Tudzynski, P. Ergot Alkaloids – Biology and Molecular Biology. The Alkaloids: Chemistry and Biology; Academic Press, 2006; Vol. 63, pp 45–86. doi:10.1016/s1099-4831(06)63002-2
    Return to citation in text: [1]
  29. Radosa, S.; Ferling, I.; Sprague, J. L.; Westermann, M.; Hillmann, F. Environ. Microbiol. 2019, 21, 1809–1820. doi:10.1111/1462-2920.14588
    Return to citation in text: [1] [2]
  30. Van Waeyenberghe, L.; Baré, J.; Pasmans, F.; Claeys, M.; Bert, W.; Haesebrouck, F.; Houf, K.; Martel, A. Environ. Microbiol. Rep. 2013, 5, 819–824. doi:10.1111/1758-2229.12082
    Return to citation in text: [1]
  31. Brunke, S.; Mogavero, S.; Kasper, L.; Hube, B. Curr. Opin. Microbiol. 2016, 32, 89–95. doi:10.1016/j.mib.2016.05.010
    Return to citation in text: [1]
  32. Tosetti, N.; Croxatto, A.; Greub, G. Microb. Pathog. 2014, 77, 125–130. doi:10.1016/j.micpath.2014.07.009
    Return to citation in text: [1] [2]
  33. Sanchez, J. F.; Somoza, A. D.; Keller, N. P.; Wang, C. C. C. Nat. Prod. Rep. 2012, 29, 351–371. doi:10.1039/c2np00084a
    Return to citation in text: [1]
  34. Show, P. L.; Oladele, K. O.; Siew, Q. Y.; Aziz Zakry, F. A.; Lan, J. C.-W.; Ling, T. C. Front. Life Sci. 2015, 8, 271–283. doi:10.1080/21553769.2015.1033653
    Return to citation in text: [1]
  35. Stötefeld, L.; Scheu, S.; Rohlfs, M. Ecol. Entomol. 2012, 37, 323–329. doi:10.1111/j.1365-2311.2012.01373.x
    Return to citation in text: [1]
  36. Rohlfs, M. Fungal secondary metabolism in the light of animal–fungus interactions: from mechanism to ecological function. In Biosynthesis and Molecular Genetics of Fungal Secondary Metabolites; Zeilinger, S.; Martín, J. F.; García-Estrada, C., Eds.; Springer: New York, NY, USA, 2015; Vol. 3, pp 177–198. doi:10.1007/978-1-4939-2531-5_9
    Return to citation in text: [1]
  37. Künzler, M. PLoS Pathog. 2018, 14, e1007184. doi:10.1371/journal.ppat.1007184
    Return to citation in text: [1]
  38. Brakhage, A. A.; Langfelder, K. Annu. Rev. Microbiol. 2002, 56, 433–455. doi:10.1146/annurev.micro.56.012302.160625
    Return to citation in text: [1] [2]
  39. Novohradská, S.; Ferling, I.; Hillmann, F. Front. Cell. Infect. Microbiol. 2017, 7, 497. doi:10.3389/fcimb.2017.00497
    Return to citation in text: [1]
  40. Latgé, J.-P. Clin. Microbiol. Rev. 1999, 12, 310–350. doi:10.1128/cmr.12.2.310
    Return to citation in text: [1]
  41. Bignell, E.; Cairns, T. C.; Throckmorton, K.; Nierman, W. C.; Keller, N. P. Philos. Trans. R. Soc., B 2016, 371, 20160023. doi:10.1098/rstb.2016.0023
    Return to citation in text: [1] [2] [3]
  42. Frisvad, J. C.; Rank, C.; Nielsen, K. F.; Larsen, T. O. Med. Mycol. 2009, 47 (Suppl. 1), S53–S71. doi:10.1080/13693780802307720
    Return to citation in text: [1]
  43. Inglis, D. O.; Binkley, J.; Skrzypek, M. S.; Arnaud, M. B.; Cerqueira, G. C.; Shah, P.; Wymore, F.; Wortman, J. R.; Sherlock, G. BMC Microbiol. 2013, 13, 91. doi:10.1186/1471-2180-13-91
    Return to citation in text: [1] [2]
  44. Lind, A. L.; Wisecaver, J. H.; Lameiras, C.; Wiemann, P.; Palmer, J. M.; Keller, N. P.; Rodrigues, F.; Goldman, G. H.; Rokas, A. PLoS Biol. 2017, 15, e2003583. doi:10.1371/journal.pbio.2003583
    Return to citation in text: [1]
  45. Heinekamp, T.; Thywißen, A.; Macheleidt, J.; Keller, S.; Valiante, V.; Brakhage, A. A. Front. Microbiol. 2013, 3, 440. doi:10.3389/fmicb.2012.00440
    Return to citation in text: [1] [2] [3]
  46. Gómez, B. L.; Nosanchuk, J. D. Curr. Opin. Infect. Dis. 2003, 16, 91–96. doi:10.1097/00001432-200304000-00005
    Return to citation in text: [1]
  47. Nguyen, K.-H.; Chollet-Krugler, M.; Gouault, N.; Tomasi, S. Nat. Prod. Rep. 2013, 30, 1490–1508. doi:10.1039/c3np70064j
    Return to citation in text: [1] [2]
  48. Brakhage, A. A.; Liebmann, B. Med. Mycol. 2005, 43 (Suppl. 1), S75–S82. doi:10.1080/13693780400028967
    Return to citation in text: [1]
  49. Jahn, B.; Langfelder, K.; Schneider, U.; Schindel, C.; Brakhage, A. A. Cell. Microbiol. 2002, 4, 793–803. doi:10.1046/j.1462-5822.2002.00228.x
    Return to citation in text: [1]
  50. Ferling, I.; Dunn, J. D.; Ferling, A.; Soldati, T.; Hillmann, F. mBio 2020, 11. doi:10.1128/mbio.00862-20
    Return to citation in text: [1] [2] [3]
  51. Lim, F. Y.; Hou, Y.; Chen, Y.; Oh, J.-H.; Lee, I.; Bugni, T. S.; Keller, N. P. Appl. Environ. Microbiol. 2012, 78, 4117–4125. doi:10.1128/aem.07710-11
    Return to citation in text: [1] [2]
  52. Berthier, E.; Lim, F. Y.; Deng, Q.; Guo, C.-J.; Kontoyiannis, D. P.; Wang, C. C. C.; Rindy, J.; Beebe, D. J.; Huttenlocher, A.; Keller, N. P. PLoS Pathog. 2013, 9, e1003289. doi:10.1371/journal.ppat.1003289
    Return to citation in text: [1]
  53. Throckmorton, K.; Lim, F. Y.; Kontoyiannis, D. P.; Zheng, W.; Keller, N. P. Environ. Microbiol. 2016, 18, 246–259. doi:10.1111/1462-2920.13007
    Return to citation in text: [1] [2] [3] [4]
  54. Hissen, A. H. T.; Wan, A. N. C.; Warwas, M. L.; Pinto, L. J.; Moore, M. M. Infect. Immun. 2005, 73, 5493–5503. doi:10.1128/iai.73.9.5493-5503.2005
    Return to citation in text: [1] [2]
  55. Schrettl, M.; Bignell, E.; Kragl, C.; Joechl, C.; Rogers, T.; Arst, H. N., Jr.; Haynes, K.; Haas, H. J. Exp. Med. 2004, 200, 1213–1219. doi:10.1084/jem.20041242
    Return to citation in text: [1] [2]
  56. Kato, N.; Suzuki, H.; Okumura, H.; Takahashi, S.; Osada, H. Biosci., Biotechnol., Biochem. 2013, 77, 1061–1067. doi:10.1271/bbb.130026
    Return to citation in text: [1]
  57. Ehlers, T.; Furness, S.; Robinson, T. P.; Zhong, H. A.; Goldsmith, D.; Aribser, J.; Bowen, J. P. Curr. Top. Med. Chem. 2016, 16, 1478–1488. doi:10.2174/1568026615666150915121204
    Return to citation in text: [1]
  58. van den Heever, J. P.; Thompson, T. S.; Curtis, J. M.; Ibrahim, A.; Pernal, S. F. J. Agric. Food Chem. 2014, 62, 2728–2737. doi:10.1021/jf4055374
    Return to citation in text: [1] [2]
  59. Mendoza, Y.; Diaz-Cetti, S.; Ramallo, G.; Santos, E.; Porrini, M.; Invernizzi, C. J. Econ. Entomol. 2017, 110, 1–5. doi:10.1093/jee/tow228
    Return to citation in text: [1]
  60. Fallon, J. P.; Reeves, E. P.; Kavanagh, K. J. Med. Microbiol. 2010, 59, 625–633. doi:10.1099/jmm.0.018192-0
    Return to citation in text: [1] [2]
  61. Fallon, J. P.; Reeves, E. P.; Kavanagh, K. Microbiology (Reading, U. K.) 2011, 157, 1481–1488. doi:10.1099/mic.0.043786-0
    Return to citation in text: [1]
  62. Guruceaga, X.; Ezpeleta, G.; Mayayo, E.; Sueiro-Olivares, M.; Abad-Diaz-De-Cerio, A.; Aguirre Urízar, J. M.; Liu, H. G.; Wiemann, P.; Bok, J. W.; Filler, S. G.; Keller, N. P.; Hernando, F. L.; Ramirez-Garcia, A.; Rementeria, A. Virulence 2018, 9, 1548–1561. doi:10.1080/21505594.2018.1526528
    Return to citation in text: [1]
  63. Pinheiro, E. A. A.; Carvalho, J. M.; dos Santos, D. C. P.; Feitosa, A. d. O.; Marinho, P. S. B.; Guilhon, G. M. S. P.; de Souza, A. D. L.; da Silva, F. M. A.; Marinho, A. M. d. R. Nat. Prod. Res. 2013, 27, 1633–1638. doi:10.1080/14786419.2012.750316
    Return to citation in text: [1] [2]
  64. Ma, H.-Y.; Song, Y.-C.; Mao, Y.-Y.; Jiang, J.-H.; Tan, R.-X.; Luo, L. Planta Med. 2006, 72, 387–392. doi:10.1055/s-2005-916235
    Return to citation in text: [1]
  65. Li, Y.-X.; Himaya, S. W. A.; Dewapriya, P.; Zhang, C.; Kim, S.-K. Mar. Drugs 2013, 11, 5063–5086. doi:10.3390/md11125063
    Return to citation in text: [1] [2]
  66. Panaccione, D. G.; Arnold, S. L. Sci. Rep. 2017, 7, 8930. doi:10.1038/s41598-017-09107-2
    Return to citation in text: [1] [2] [3]
  67. Du, R. H.; Li, E. G.; Cao, Y.; Song, Y. C.; Tan, R. X. Life Sci. 2011, 89, 235–240. doi:10.1016/j.lfs.2011.06.015
    Return to citation in text: [1] [2] [3]
  68. Macheleidt, J.; Scherlach, K.; Neuwirth, T.; Schmidt-Heck, W.; Straßburger, M.; Spraker, J.; Baccile, J. A.; Schroeder, F. C.; Keller, N. P.; Hertweck, C.; Heinekamp, T.; Brakhage, A. A. Mol. Microbiol. 2015, 96, 148–162. doi:10.1111/mmi.12926
    Return to citation in text: [1]
  69. Lim, F. Y.; Ames, B.; Walsh, C. T.; Keller, N. P. Cell. Microbiol. 2014, 16, 1267–1283. doi:10.1111/cmi.12284
    Return to citation in text: [1]
  70. Garcia Silva, M.; Araçari Jacometti Cardoso Furtado, N.; Tallarico Pupo, M.; José Vieira Fonseca, M.; Said, S.; Alves da Silva Filho, A.; Kenupp Bastos, J. Microbiol. Res. 2004, 159, 317–322. doi:10.1016/j.micres.2004.06.003
    Return to citation in text: [1]
  71. Belofsky, G. N.; Anguera, M.; Jensen, P. R.; Fenical, W.; Köck, M. Chem. – Eur. J. 2000, 6, 1355–1360. doi:10.1002/(sici)1521-3765(20000417)6:8<1355::aid-chem1355>3.0.co;2-s
    Return to citation in text: [1]
  72. Li, X.-J.; Zhang, Q.; Zhang, A.-L.; Gao, J.-M. J. Agric. Food Chem. 2012, 60, 3424–3431. doi:10.1021/jf300146n
    Return to citation in text: [1] [2] [3] [4] [5] [6] [7]
  73. Baccile, J. A.; Spraker, J. E.; Le, H. H.; Brandenburger, E.; Gomez, C.; Bok, J. W.; Macheleidt, J.; Brakhage, A. A.; Hoffmeister, D.; Keller, N. P.; Schroeder, F. C. Nat. Chem. Biol. 2016, 12, 419–424. doi:10.1038/nchembio.2061
    Return to citation in text: [1]
  74. Khalid, S.; Baccile, J. A.; Spraker, J. E.; Tannous, J.; Imran, M.; Schroeder, F. C.; Keller, N. P. ACS Chem. Biol. 2018, 13, 171–179. doi:10.1021/acschembio.7b00731
    Return to citation in text: [1]
  75. González-Lobato, L.; Real, R.; Prieto, J. G.; Álvarez, A. I.; Merino, G. Eur. J. Pharmacol. 2010, 644, 41–48. doi:10.1016/j.ejphar.2010.07.016
    Return to citation in text: [1] [2]
  76. Lehner, S. M.; Atanasova, L.; Neumann, N. K. N.; Krska, R.; Lemmens, M.; Druzhinina, I. S.; Schuhmacher, R. Appl. Environ. Microbiol. 2013, 79, 18–31. doi:10.1128/aem.02339-12
    Return to citation in text: [1]
  77. Ali, H.; Ries, M. I.; Lankhorst, P. P.; van der Hoeven, R. A. M.; Schouten, O. L.; Noga, M.; Hankemeier, T.; van Peij, N. N. M. E.; Bovenberg, R. A. L.; Vreeken, R. J.; Driessen, A. J. M. PLoS One 2014, 9, e98212. doi:10.1371/journal.pone.0098212
    Return to citation in text: [1]
  78. Scharf, D. H.; Brakhage, A. A.; Mukherjee, P. K. Environ. Microbiol. 2016, 18, 1096–1109. doi:10.1111/1462-2920.13080
    Return to citation in text: [1] [2] [3]
  79. Yamada, A.; Kataoka, T.; Nagai, K. Immunol. Lett. 2000, 71, 27–32. doi:10.1016/s0165-2478(99)00155-8
    Return to citation in text: [1] [2] [3]
  80. Schlam, D.; Canton, J.; Carreño, M.; Kopinski, H.; Freeman, S. A.; Grinstein, S.; Fairn, G. D. mBio 2016, 7. doi:10.1128/mbio.02242-15
    Return to citation in text: [1] [2] [3]
  81. Gardiner, D. M.; Waring, P.; Howlett, B. J. Microbiology (Reading, U. K.) 2005, 151, 1021–1032. doi:10.1099/mic.0.27847-0
    Return to citation in text: [1] [2] [3]
  82. Hillmann, F.; Novohradská, S.; Mattern, D. J.; Forberger, T.; Heinekamp, T.; Westermann, M.; Winckler, T.; Brakhage, A. A. Environ. Microbiol. 2015, 17, 2858–2869. doi:10.1111/1462-2920.12808
    Return to citation in text: [1] [2] [3] [4]
  83. Mitsuguchi, H.; Seshime, Y.; Fujii, I.; Shibuya, M.; Ebizuka, Y.; Kushiro, T. J. Am. Chem. Soc. 2009, 131, 6402–6411. doi:10.1021/ja8095976
    Return to citation in text: [1] [2] [3]
  84. Lodeiro, S.; Xiong, Q.; Wilson, W. K.; Ivanova, Y.; Smith, M. L.; May, G. S.; Matsuda, S. P. T. Org. Lett. 2009, 11, 1241–1244. doi:10.1021/ol802696a
    Return to citation in text: [1]
  85. Kimura, M.; Kushiro, T.; Shibuya, M.; Ebizuka, Y.; Abe, I. Biochem. Biophys. Res. Commun. 2010, 391, 899–902. doi:10.1016/j.bbrc.2009.11.160
    Return to citation in text: [1]
  86. Ganaha, M.; Yoshii, K.; Ōtsuki, Y.; Iguchi, M.; Okamoto, Y.; Iseki, K.; Ban, S.; Ishiyama, A.; Hokari, R.; Iwatsuki, M.; Otoguro, K.; Ōmura, S.; Hashimoto, T.; Noji, M.; Umeyama, A. Chem. Pharm. Bull. 2016, 64, 988–990. doi:10.1248/cpb.c16-00220
    Return to citation in text: [1] [2]
  87. Amitani, R.; Taylor, G.; Elezis, E.-N.; Llewellyn-Jones, C.; Mitchell, J.; Kuze, F.; Cole, P. J.; Wilson, R. Infect. Immun. 1995, 63, 3266–3271. doi:10.1128/iai.63.9.3266-3271.1995
    Return to citation in text: [1] [2]
  88. Kong, F.-D.; Huang, X.-L.; Ma, Q.-Y.; Xie, Q.-Y.; Wang, P.; Chen, P.-W.; Zhou, L.-M.; Yuan, J.-Z.; Dai, H.-F.; Luo, D.-Q.; Zhao, Y.-X. J. Nat. Prod. 2018, 81, 1869–1876. doi:10.1021/acs.jnatprod.8b00382
    Return to citation in text: [1] [2]
  89. Yin, W.-B.; Baccile, J. A.; Bok, J. W.; Chen, Y.; Keller, N. P.; Schroeder, F. C. J. Am. Chem. Soc. 2013, 135, 2064–2067. doi:10.1021/ja311145n
    Return to citation in text: [1]
  90. Wiemann, P.; Lechner, B. E.; Baccile, J. A.; Velk, T. A.; Yin, W.-B.; Bok, J. W.; Pakala, S.; Losada, L.; Nierman, W. C.; Schroeder, F. C. Front. Microbiol. 2014, 5, 530. doi:10.3389/fmicb.2014.00530
    Return to citation in text: [1]
  91. König, C. C.; Scherlach, K.; Schroeckh, V.; Horn, F.; Nietzsche, S.; Brakhage, A. A.; Hertweck, C. ChemBioChem 2013, 14, 938–942. doi:10.1002/cbic.201300070
    Return to citation in text: [1]
  92. Chooi, Y.-H.; Fang, J.; Liu, H.; Filler, S. G.; Wang, P.; Tang, Y. Org. Lett. 2013, 15, 780–783. doi:10.1021/ol303435y
    Return to citation in text: [1]
  93. Andersen, M. R.; Nielsen, J. B.; Klitgaard, A.; Petersen, L. M.; Zachariasen, M.; Hansen, T. J.; Blicher, L. H.; Gotfredsen, C. H.; Larsen, T. O.; Nielsen, K. F.; Mortensen, U. H. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, E99–E107. doi:10.1073/pnas.1205532110
    Return to citation in text: [1]
  94. Mehedi, M. A. U.; Molla, A. H.; Khondkar, P.; Sultana, S.; Islam, M. A.; Rashid, M. A.; Chowdhury, R. Asian J. Chem. 2010, 22, 2611–2614.
    Return to citation in text: [1]
  95. Wiemann, P.; Guo, C.-J.; Palmer, J. M.; Sekonyela, R.; Wang, C. C. C.; Keller, N. P. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 17065–17070. doi:10.1073/pnas.1313258110
    Return to citation in text: [1] [2] [3]
  96. Ishikawa, M.; Ninomiya, T.; Akabane, H.; Kushida, N.; Tsujiuchi, G.; Ohyama, M.; Gomi, S.; Shito, K.; Murata, T. Bioorg. Med. Chem. Lett. 2009, 19, 1457–1460. doi:10.1016/j.bmcl.2009.01.029
    Return to citation in text: [1]
  97. Maiya, S.; Grundmann, A.; Li, X.; Li, S.-M.; Turner, G. ChemBioChem 2007, 8, 1736–1743. doi:10.1002/cbic.200700202
    Return to citation in text: [1] [2]
  98. Omura, S.; Tomoda, H.; Kim, Y. K.; Nishida, H. J. Antibiot. 1993, 46, 1168–1169. doi:10.7164/antibiotics.46.1168
    Return to citation in text: [1] [2]
  99. Hu, J.; Furutani, A.; Yamamoto, K.; Oyama, K.; Mitomi, M.; Anzai, H. Biotechnol. Biotechnol. Equip. 2014, 28, 818–826. doi:10.1080/13102818.2014.960140
    Return to citation in text: [1] [2]
  100. Goto, K.; Horikoshi, R.; Mitomi, M.; Oyama, K.; Hirose, T.; Sunazuka, T.; Ōmura, S. J. Antibiot. 2018, 71, 785–797. doi:10.1038/s41429-018-0064-9
    Return to citation in text: [1] [2]
  101. VanMiddlesworth, F.; Dufresne, C.; Wincott, F. E.; Mosley, R. T.; Wilson, K. E. Tetrahedron Lett. 1992, 33, 297–300. doi:10.1016/s0040-4039(00)74115-3
    Return to citation in text: [1]
  102. VanMiddlesworth, F.; Giacobbe, R. A.; Lopez, M.; Garrity, G.; Bland, J. A.; Bartizal, K.; Fromtling, R. A.; Polishook, J.; Zweerink, M.; Edison, A. M. J. Antibiot. 1992, 45, 861–867. doi:10.7164/antibiotics.45.861
    Return to citation in text: [1]
  103. Rank, C. Mapping of secondary metabolism in biotechnologically important Aspergillus species. Ph.D. Thesis, Technical University of Denmark, Lyngby, Denmark, 2010.
    Return to citation in text: [1]
  104. Kobayashi, S.; Furuta, T.; Hayashi, T.; Nishijima, M.; Hanada, K. J. Am. Chem. Soc. 1998, 120, 908–919. doi:10.1021/ja9730829
    Return to citation in text: [1]
  105. Mattern, D. J.; Schoeler, H.; Weber, J.; Novohradská, S.; Kraibooj, K.; Dahse, H.-M.; Hillmann, F.; Valiante, V.; Figge, M. T.; Brakhage, A. A. Appl. Microbiol. Biotechnol. 2015, 99, 10151–10161. doi:10.1007/s00253-015-6898-1
    Return to citation in text: [1] [2] [3]
  106. Balan, J.; Ebringer, L.; Nemec, P.; Kováč, Š.; Dobias, J. J. Antibiot., Ser. A 1963, 16, 157–160.
    Return to citation in text: [1]
  107. Gauthier, T.; Wang, X.; Sifuentes Dos Santos, J.; Fysikopoulos, A.; Tadrist, S.; Canlet, C.; Artigot, M. P.; Loiseau, N.; Oswald, I. P.; Puel, O. PLoS One 2012, 7, e29906. doi:10.1371/journal.pone.0029906
    Return to citation in text: [1] [2] [3]
  108. Khoufache, K.; Puel, O.; Loiseau, N.; Delaforge, M.; Rivollet, D.; Coste, A.; Cordonnier, C.; Escudier, E.; Botterel, F.; Bretagne, S. BMC Microbiol. 2007, 7, No. 1. doi:10.1186/1471-2180-7-1
    Return to citation in text: [1]
  109. Gallagher, R. T.; Latch, G. C. M. Appl. Environ. Microbiol. 1977, 33, 730–731. doi:10.1128/aem.33.3.730-731.1977
    Return to citation in text: [1]
  110. Wang, F.; Fang, Y.; Zhu, T.; Zhang, M.; Lin, A.; Gu, Q.; Zhu, W. Tetrahedron 2008, 64, 7986–7991. doi:10.1016/j.tet.2008.06.013
    Return to citation in text: [1]
  111. Lim, F. Y.; Won, T. H.; Raffa, N.; Baccile, J. A.; Wisecaver, J.; Rokas, A.; Schroeder, F. C.; Keller, N. P. mBio 2018, 9. doi:10.1128/mbio.00785-18
    Return to citation in text: [1]
  112. Bok, J. W.; Chung, D.; Balajee, S. A.; Marr, K. A.; Andes, D.; Nielsen, K. F.; Frisvad, J. C.; Kirby, K. A.; Keller, N. P. Infect. Immun. 2006, 74, 6761–6768. doi:10.1128/iai.00780-06
    Return to citation in text: [1] [2]
  113. Bell, M. R.; Johnson, J. R.; Wildi, B. S.; Woodward, R. B. J. Am. Chem. Soc. 1958, 80, 1001. doi:10.1021/ja01537a065
    Return to citation in text: [1]
  114. Bok, J. W.; Balajee, S. A.; Marr, K. A.; Andes, D.; Nielsen, K. F.; Frisvad, J. C.; Keller, N. P. Eukaryotic Cell 2005, 4, 1574–1582. doi:10.1128/ec.4.9.1574-1582.2005
    Return to citation in text: [1]
  115. Cramer, R. A., Jr.; Gamcsik, M. P.; Brooking, R. M.; Najvar, L. K.; Kirkpatrick, W. R.; Patterson, T. F.; Balibar, C. J.; Graybill, J. R.; Perfect, J. R.; Abraham, S. N.; Steinbach, W. J. Eukaryotic Cell 2006, 5, 972–980. doi:10.1128/ec.00049-06
    Return to citation in text: [1] [2]
  116. Kupfahl, C.; Heinekamp, T.; Geginat, G.; Ruppert, T.; Härtl, A.; Hof, H.; Brakhage, A. A. Mol. Microbiol. 2006, 62, 292–302. doi:10.1111/j.1365-2958.2006.05373.x
    Return to citation in text: [1]
  117. Scharf, D. H.; Remme, N.; Heinekamp, T.; Hortschansky, P.; Brakhage, A. A.; Hertweck, C. J. Am. Chem. Soc. 2010, 132, 10136–10141. doi:10.1021/ja103262m
    Return to citation in text: [1]
  118. Schrettl, M.; Carberry, S.; Kavanagh, K.; Haas, H.; Jones, G. W.; O'Brien, J.; Nolan, A.; Stephens, J.; Fenelon, O.; Doyle, S. PLoS Pathog. 2010, 6, e1000952. doi:10.1371/journal.ppat.1000952
    Return to citation in text: [1]
  119. McDonagh, A.; Fedorova, N. D.; Crabtree, J.; Yu, Y.; Kim, S.; Chen, D.; Loss, O.; Cairns, T.; Goldman, G.; Armstrong-James, D.; Haynes, K.; Haas, H.; Schrettl, M.; May, G.; Nierman, W. C.; Bignell, E. PLoS Pathog. 2008, 4, e1000154. doi:10.1371/journal.ppat.1000154
    Return to citation in text: [1]
  120. Sugui, J. A.; Kim, H. S.; Zarember, K. A.; Chang, Y. C.; Gallin, J. I.; Nierman, W. C.; Kwon-Chung, K. J. PLoS One 2008, 3, e2655. doi:10.1371/journal.pone.0002655
    Return to citation in text: [1]
  121. Sugui, J. A.; Pardo, J.; Chang, Y. C.; Zarember, K. A.; Nardone, G.; Galvez, E. M.; Müllbacher, A.; Gallin, J. I.; Simon, M. M.; Kwon-Chung, K. J. Eukaryotic Cell 2007, 6, 1562–1569. doi:10.1128/ec.00141-07
    Return to citation in text: [1]
  122. Vargas, W. A.; Mukherjee, P. K.; Laughlin, D.; Wiest, A.; Moran-Diez, M. E.; Kenerley, C. M. Microbiology (Reading, U. K.) 2014, 160, 2319–2330. doi:10.1099/mic.0.079210-0
    Return to citation in text: [1]
  123. Coyle, C. M.; Kenaley, S. C.; Rittenour, W. R.; Panaccione, D. G. Mycologia 2007, 99, 804–811. doi:10.1080/15572536.2007.11832512
    Return to citation in text: [1]
  124. Perrin, R. M.; Fedorova, N. D.; Bok, J. W.; Cramer, R. A.; Wortman, J. R.; Kim, H. S.; Nierman, W. C.; Keller, N. P. PLoS Pathog. 2007, 3, e50. doi:10.1371/journal.ppat.0030050
    Return to citation in text: [1] [2] [3]
  125. Twumasi-Boateng, K.; Yu, Y.; Chen, D.; Gravelat, F. N.; Nierman, W. C.; Sheppard, D. C. Eukaryotic Cell 2009, 8, 104–115. doi:10.1128/ec.00265-08
    Return to citation in text: [1]
  126. Upadhyay, S.; Torres, G.; Lin, X. Eukaryotic Cell 2013, 12, 1641–1652. doi:10.1128/ec.00217-13
    Return to citation in text: [1]
  127. Hanson, F. R.; Eble, T. E. J. Bacteriol. 1949, 58, 527–529. doi:10.1128/jb.58.4.527-529.1949
    Return to citation in text: [1]
  128. Lin, H.-C.; Chooi, Y.-H.; Dhingra, S.; Xu, W.; Calvo, A. M.; Tang, Y. J. Am. Chem. Soc. 2013, 135, 4616–4619. doi:10.1021/ja312503y
    Return to citation in text: [1]
  129. Sin, N.; Meng, L.; Wang, M. Q. W.; Wen, J. J.; Bornmann, W. G.; Crews, C. M. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 6099–6103. doi:10.1073/pnas.94.12.6099
    Return to citation in text: [1] [2]
  130. Mauriz, J. L.; Martín-Renedo, J.; García-Palomo, A.; Tuñón, M. J.; González-Gallego, J. Curr. Drug Targets 2010, 11, 1439–1457. doi:10.2174/1389450111009011439
    Return to citation in text: [1]
  131. Vetro, J. A.; Dummitt, B.; Chang, Y.-H. Methionine Aminopeptidase. In Aminopeptidases in Biology and Disease; Hooper, N. M.; Lendeckel, U., Eds.; Proteases in Biology and Disease, Vol. 2; Springer: Boston, MA, USA, 2004; pp 17–44. doi:10.1007/978-1-4419-8869-0_2
    Return to citation in text: [1]
  132. Conrad, T.; Kniemeyer, O.; Henkel, S. G.; Krüger, T.; Mattern, D. J.; Valiante, V.; Guthke, R.; Jacobsen, I. D.; Brakhage, A. A.; Vlaic, S.; Linde, J. BMC Syst. Biol. 2018, 12, 88. doi:10.1186/s12918-018-0620-8
    Return to citation in text: [1] [2]
  133. Netzker, T.; Fischer, J.; Weber, J.; Mattern, D. J.; König, C. C.; Valiante, V.; Schroeckh, V.; Brakhage, A. A. Front. Microbiol. 2015, 6, 299. doi:10.3389/fmicb.2015.00299
    Return to citation in text: [1]
  134. Guruceaga, X.; Perez-Cuesta, U.; Abad-Diaz de Cerio, A.; Gonzalez, O.; Alonso, R. M.; Hernando, F. L.; Ramirez-Garcia, A.; Rementeria, A. Toxins 2019, 12, 7. doi:10.3390/toxins12010007
    Return to citation in text: [1]
  135. Molina, J.-M.; Tourneur, M.; Sarfati, C.; Chevret, S.; de Gouvello, A.; Gobert, J.-G.; Balkan, S.; Derouin, F. N. Engl. J. Med. 2002, 346, 1963–1969. doi:10.1056/nejmoa012924
    Return to citation in text: [1]
  136. Keller, N.; Bok, J.; Chung, D.; Perrin, R. M.; Keats Shwab, E. Med. Mycol. 2006, 44 (Suppl. 1), S83–S85. doi:10.1080/13693780600835773
    Return to citation in text: [1]
  137. Romsdahl, J.; Wang, C. C. C. Med. Chem. Commun. 2019, 10, 840–866. doi:10.1039/c9md00054b
    Return to citation in text: [1]
  138. Wang, J.; Sheppard, G. S.; Lou, P.; Kawai, M.; BaMaung, N.; Erickson, S. A.; Tucker-Garcia, L.; Park, C.; Bouska, J.; Wang, Y.-C. Cancer Res. 2003, 63, 7861–7869.
    Return to citation in text: [1]
  139. Yamaoka, M.; Yamamoto, T.; Ikeyama, S.; Sudo, K.; Fujita, T. Cancer Res. 1993, 53, 5233–5236.
    Return to citation in text: [1]
  140. Tucker, L. A.; Zhang, Q.; Sheppard, G. S.; Lou, P.; Jiang, F.; McKeegan, E.; Lesniewski, R.; Davidsen, S. K.; Bell, R. L.; Wang, J. Oncogene 2008, 27, 3967–3976. doi:10.1038/onc.2008.14
    Return to citation in text: [1]
  141. McCowen, M. C.; Callender, M. E.; Lawlis, J. F., Jr. Science 1951, 113, 202–203. doi:10.1126/science.113.2930.202
    Return to citation in text: [1]
  142. Arico-Muendel, C.; Centrella, P. A.; Contonio, B. D.; Morgan, B. A.; O’Donovan, G.; Paradise, C. L.; Skinner, S. R.; Sluboski, B.; Svendsen, J. L.; White, K. F.; Debnath, A.; Gut, J.; Wilson, N.; McKerrow, J. H.; DeRisi, J. L.; Rosenthal, P. J.; Chiang, P. K. Bioorg. Med. Chem. Lett. 2009, 19, 5128–5131. doi:10.1016/j.bmcl.2009.07.029
    Return to citation in text: [1]
  143. Eisenman, H. C.; Casadevall, A. Appl. Microbiol. Biotechnol. 2012, 93, 931–940. doi:10.1007/s00253-011-3777-2
    Return to citation in text: [1]
  144. Cecchini, M. M.; Reale, S.; Manini, P.; d'Ischia, M.; De Angelis, F. Chem. – Eur. J. 2017, 23, 8092–8098. doi:10.1002/chem.201701951
    Return to citation in text: [1] [2]
  145. Tsai, H.-F.; Washburn, R. G.; Chang, Y. C.; Kwon‐Chung, K. J. Mol. Microbiol. 1997, 26, 175–183. doi:10.1046/j.1365-2958.1997.5681921.x
    Return to citation in text: [1]
  146. Schmaler-Ripcke, J.; Sugareva, V.; Gebhardt, P.; Winkler, R.; Kniemeyer, O.; Heinekamp, T.; Brakhage, A. A. Appl. Environ. Microbiol. 2009, 75, 493–503. doi:10.1128/aem.02077-08
    Return to citation in text: [1]
  147. Perez-Cuesta, U.; Aparicio-Fernandez, L.; Guruceaga, X.; Martin-Souto, L.; Abad-Diaz-de-Cerio, A.; Antoran, A.; Buldain, I.; Hernando, F. L.; Ramirez-Garcia, A.; Rementeria, A. Int. Microbiol. 2020, 23, 55–63. doi:10.1007/s10123-019-00078-0
    Return to citation in text: [1] [2] [3] [4]
  148. Tsai, H.-F.; Wheeler, M. H.; Chang, Y. C.; Kwon-Chung, K. J. J. Bacteriol. 1999, 181, 6469–6477. doi:10.1128/jb.181.20.6469-6477.1999
    Return to citation in text: [1]
  149. Fujii, I.; Yasuoka, Y.; Tsai, H.-F.; Chang, Y. C.; Kwon-Chung, K. J.; Ebizuka, Y. J. Biol. Chem. 2004, 279, 44613–44620. doi:10.1074/jbc.m406758200
    Return to citation in text: [1]
  150. Langfelder, K.; Jahn, B.; Gehringer, H.; Schmidt, A.; Wanner, G.; Brakhage, A. A. Med. Microbiol. Immunol. 1998, 187, 79–89. doi:10.1007/s004300050077
    Return to citation in text: [1]
  151. Tsai, H.-F.; Fujii, I.; Watanabe, A.; Wheeler, M. H.; Chang, Y. C.; Yasuoka, Y.; Ebizuka, Y.; Kwon-Chung, K. J. J. Biol. Chem. 2001, 276, 29292–29298. doi:10.1074/jbc.m101998200
    Return to citation in text: [1]
  152. Sugareva, V.; Härtl, A.; Brock, M.; Hübner, K.; Rohde, M.; Heinekamp, T.; Brakhage, A. A. Arch. Microbiol. 2006, 186, 345–355. doi:10.1007/s00203-006-0144-2
    Return to citation in text: [1]
  153. Manini, P.; Bietti, M.; Galeotti, M.; Salamone, M.; Lanzalunga, O.; Cecchini, M. M.; Reale, S.; Crescenzi, O.; Napolitano, A.; De Angelis, F.; Barone, V.; d’Ischia, M. ACS Omega 2018, 3, 3918–3927. doi:10.1021/acsomega.8b00155
    Return to citation in text: [1]
  154. Chai, L. Y. A.; Netea, M. G.; Sugui, J.; Vonk, A. G.; van de Sande, W. W. J.; Warris, A.; Kwon-Chung, K. J.; Kullberg, B. J. Immunobiology 2010, 215, 915–920. doi:10.1016/j.imbio.2009.10.002
    Return to citation in text: [1]
  155. Thywißen, A.; Heinekamp, T.; Dahse, H.-M.; Schmaler-Ripcke, J.; Nietsche, S.; Zipfel, P. F.; Brakhage, A. A. Front. Microbiol. 2011, 2, 96. doi:10.3389/fmicb.2011.00096
    Return to citation in text: [1]
  156. Stappers, M. H. T.; Clark, A. E.; Aimanianda, V.; Bidula, S.; Reid, D. M.; Asamaphan, P.; Hardison, S. E.; Dambuza, I. M.; Valsecchi, I.; Kerscher, B.; Plato, A.; Wallace, C. A.; Yuecel, R.; Hebecker, B.; da Glória Teixeira Sousa, M.; Cunha, C.; Liu, Y.; Feizi, T.; Brakhage, A. A.; Kwon-Chung, K. J.; Gow, N. A. R.; Zanda, M.; Piras, M.; Zanato, C.; Jaeger, M.; Netea, M. G.; van de Veerdonk, F. L.; Lacerda, J. F.; Campos, A.; Carvalho, A.; Willment, J. A.; Latgé, J.-P.; Brown, G. D. Nature 2018, 555, 382–386. doi:10.1038/nature25974
    Return to citation in text: [1]
  157. Wong, S. S. W.; Rani, M.; Dodagatta-Marri, E.; Ibrahim-Granet, O.; Kishore, U.; Bayry, J.; Latgé, J.-P.; Sahu, A.; Madan, T.; Aimanianda, V. J. Biol. Chem. 2018, 293, 4901–4912. doi:10.1074/jbc.m117.815852
    Return to citation in text: [1]
  158. Kozlovskii, A. G.; Zhelifonova, V. P.; Antipova, T. V. Appl. Biochem. Microbiol. 2013, 49, 1–10. doi:10.1134/s0003683813010092
    Return to citation in text: [1]
  159. Robinson, S. L.; Panaccione, D. G. Toxins 2015, 7, 201–218. doi:10.3390/toxins7010201
    Return to citation in text: [1]
  160. Li, S.-M. J. Antibiot. 2011, 64, 45–49. doi:10.1038/ja.2010.128
    Return to citation in text: [1] [2]
  161. Grundmann, A.; Li, S.-M. Microbiology (Reading, U. K.) 2005, 151, 2199–2207. doi:10.1099/mic.0.27962-0
    Return to citation in text: [1]
  162. Yamazaki, M.; Fujimoto, H.; Kawasaki, T. Chem. Pharm. Bull. 1980, 28, 245–254. doi:10.1248/cpb.28.245
    Return to citation in text: [1]
  163. Cui, C.-B.; Kakeya, H.; Osada, H. Tetrahedron 1997, 53, 59–72. doi:10.1016/s0040-4020(96)00978-7
    Return to citation in text: [1]
  164. Rabindran, S. K.; Ross, D. D.; Doyle, L. A.; Yang, W.; Greenberger, L. M. Cancer Res. 2000, 60, 47–50.
    Return to citation in text: [1]
  165. Chain, E.; Florey, H.; Jennings, M.; Williams, T. Br. J. Exp. Pathol. 1943, 24, 108.
    Return to citation in text: [1]
  166. Rank, C.; Larsen, T. O.; Frisvad, J. C. Functional systems biology of Aspergillus. In Aspergillus: molecular biology and genomics; Machida, M.; Gomi, K., Eds.; Caister Academic Press: Norfolk, UK, 2010; pp 173–198.
    Return to citation in text: [1]
  167. Tamiya, H.; Ochiai, E.; Kikuchi, K.; Yahiro, M.; Toyotome, T.; Watanabe, A.; Yaguchi, T.; Kamei, K. J. Infect. Chemother. 2015, 21, 385–391. doi:10.1016/j.jiac.2015.01.005
    Return to citation in text: [1]
  168. Cole, R. J.; Jarvis, B. B.; Schweikert, M. A. Handbook of secondary fungal metabolites; Elsevier, 2003.
    Return to citation in text: [1]
  169. Lv, J.-M.; Hu, D.; Gao, H.; Kushiro, T.; Awakawa, T.; Chen, G.-D.; Wang, C.-X.; Abe, I.; Yao, X.-S. Nat. Commun. 2017, 8, 1644. doi:10.1038/s41467-017-01813-9
    Return to citation in text: [1] [2] [3]
  170. Tomoda, H.; Nishida, H.; Kim, Y. K.; Obata, R.; Sunazuka, T.; Omura, S.; Bordner, J.; Guadliana, M.; Dormer, P. G.; Smith, A. B., III. J. Am. Chem. Soc. 1994, 116, 12097–12098. doi:10.1021/ja00105a078
    Return to citation in text: [1] [2]
  171. Kim, Y. K.; Tomoda, H.; Nishida, H.; Sunazuka, T.; Obata, R.; Omura, S. J. Antibiot. 1994, 47, 154–162. doi:10.7164/antibiotics.47.154
    Return to citation in text: [1]
  172. Itoh, T.; Tokunaga, K.; Matsuda, Y.; Fujii, I.; Abe, I.; Ebizuka, Y.; Kushiro, T. Nat. Chem. 2010, 2, 858–864. doi:10.1038/nchem.764
    Return to citation in text: [1]
  173. Das, A.; Davis, M. A.; Tomoda, H.; Ômura, S.; Rudel, L. L. J. Biol. Chem. 2008, 283, 10453–10460. doi:10.1074/jbc.m709460200
    Return to citation in text: [1]
  174. Ohshiro, T.; Matsuda, D.; Sakai, K.; Degirolamo, C.; Yagyu, H.; Rudel, L. L.; Ōmura, S.; Ishibashi, S.; Tomoda, H. Arterioscler., Thromb., Vasc. Biol. 2011, 31, 1108–1115. doi:10.1161/atvbaha.111.223552
    Return to citation in text: [1]
  175. Raffa, N.; Keller, N. P. PLoS Pathog. 2019, 15, e1007606. doi:10.1371/journal.ppat.1007606
    Return to citation in text: [1]

© 2021 Boysen et al.; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0). Please note that the reuse, redistribution and reproduction in particular requires that the author(s) and source are credited and that individual graphics may be subject to special legal provisions.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms)

Other Beilstein-Institut Open Science Activities
Journal Logo
Institut Logo
Preprint Logo
Symposia Logo